Search Results

You are looking at 1 - 10 of 126 items for :

  • "mammography" x
  • Refine by Access: All x
Clear All
Full access

Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016

Kathryn P. Lowry, Katherine A. Callaway, Janie M. Lee, Fang Zhang, Dennis Ross-Degnan, J. Frank Wharam, Karla Kerlikowske, Karen J. Wernli, Allison W. Kurian, Louise M. Henderson, and Natasha K. Stout

Background Surveillance mammography is an integral component of survivorship care for women with a personal history of breast cancer to detect both local recurrences and new primary breast cancers. In contrast to screening guidelines for women

Full access

Factors Associated With False-Positive Recalls in Mammography Screening

Xinhe Mao, Wei He, Keith Humphreys, Mikael Eriksson, Natalie Holowko, Fredrik Strand, Per Hall, and Kamila Czene

Background Mammography screening reduces breast cancer mortality by an estimated 26% to 41%. 1 , 2 However, false-positive recalls—recalling women with abnormal mammograms who, on further testing, are not found to have breast cancer—can cause

Full access

Receipt of Screening Mammography by Insured Women Diagnosed With Breast Cancer and Impact on Outcomes

Marissa B. Lawson, Christoph I. Lee, Daniel S. Hippe, Shasank Chennupati, Catherine R. Fedorenko, Kathleen E. Malone, Scott D. Ramsey, and Janie M. Lee

Background Over the last several decades, breast cancer mortality in the United States has declined substantially. 1 , 2 This decrease has been attributed in part to screening mammography and its ability to detect localized asymptomatic

Full access

An Overview of Mammography: Benefits and Limitations

Robert A. Smith

Kerlikowske K . Is there a downside to elderly women undergoing screening mammography? [editorial; comment] . J Natl Cancer Inst 1998 ; 90 : 1322 – 1323 . 7 Smith-Bindman R Kerlikowske K Gebretsadik T . Is screening mammography effective in

Full access

HSR24-155: Disparities in Real-World Screening Mammography Compliance Rates by Body Mass Index and Mobility-Restricting Diagnosis—A Commercial Claims-Based Analysis

Julia Olsen, Scott Pohlman, and Jason Shames

Background: Screening mammography plays a key role in early breast cancer detection. This population-based claims analysis examines screening mammography compliance rates in populations prone to limitations or challenges with positioning during

Full access

Screening Mammography for Average-Risk Women: The Controversy and NCCN's Position

Mark A. Helvie and Therese B. Bevers

Recognizing that the purpose of breast cancer screening is to decrease breast cancer mortality and morbidity, NCCN continues to recommend annual screening mammography beginning at age 40 years for average-risk women. Mammographic screening and

Full access

Differences in Patient Screening Mammography Rates Associated With Internist Gender and Level of Training and Change Following the 2009 U.S. Preventive Services Task Force Guidelines

Dawn J. Brooks

screening mammography and the benefits of adjuvant systemic therapies, the mortality rate due to breast cancer has decreased over the past 25 years. 2 Nonetheless, considerable professional disagreement exists over the most appropriate age at which to begin

Full access

Mammographic Breast Density: Effect on Imaging and Breast Cancer Risk

Renee W. Pinsky and Mark A. Helvie

screen mammography, the x-ray energy is converted to an image on film, whereas in digital imaging the energy is converted into an electronic signal that can be projected on a computer screen and manipulated. A mammogram that appears primarily white is

Full access

HSR19-079: Disparities in Accessing Screening Mammography: Opportunities for Improving Diagnostic Outcomes

Nila Alsheik, Zhaohui Su, Anna Lafontant, Gregory Donadio, Kathleen Troeger, Scott Pohlman, Melinda Talley, Vandana Menon, and Emily Conant

Introduction: Screening mammography is a key component of secondary prevention programs targeting reductions in breast cancer mortality. The early detection of cancers facilitates treatment at a more curable, locoregionally limited stage. We

Full access

QIM19-119: Validity of the French-Language Mammography Satisfaction Instrument Evaluating Women’s Satisfaction With an Organized Breast Cancer Screening Program: A Confirmatory Study

Isabelle Bairati, Anne-Sophie Julien, and Jocelyne Chiquette

Background: To evaluate the quality of an organized mammography screening program based on the perception of screened women, we developed and validated the French-language Mammography Satisfaction Instrument (MSI). The study objective was to